US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wellgistics Health Inc.

1.69

-0.0500-2.87%

Post-market: 1.730.0400+2.37%19:39 EDT

Volume:165.27K

Turnover:280.09K

Market Cap:121.44M

PE:-2.11

High:1.90

Open:1.78

Low:1.42

Close:1.74

Loading ...

Overview Company News Filings

Wellgistics Health Achieves SOC 2 Type 1 Compliance

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models

Wellgistics Health Appoints Brian Norton to Succeed Tim Canning as CEO

MT Newswires Live

Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure

THOMSON REUTERS

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure

BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth

BUZZ-U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life Sciences

BUZZ-Wellgistics rises on collaboration with Protega Pharmaceuticals

BRIEF-Protega Pharmaceuticals Collaborates With Wellgistics To Support Pharmacist Education

Protega Pharmaceuticals Collaborates With Wellgistics to Support Pharmacist Education and Increase Patient Access to the First and Only FDA-Approved Abuse-Deterrent Immediate-Release Opioid, Roxybond™

THOMSON REUTERS

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

Wellgistics Health Expands with Tollo Health Partnership

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

THOMSON REUTERS

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

BRIEF-Wellgistics Health Announces Pricing Of $4.0 Million Initial Public Offering

Wellgistics Health Prices $4 Million IPO

MT Newswires Live

Wellgistics Health Inc - Prices IPO of 888,889 Shares at $4.50 Each

THOMSON REUTERS

Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/WGRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WGRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WGRX\",,,,,undefined,":{"symbol":"WGRX","market":"US","secType":"STK","nameCN":"Wellgistics Health Inc.","latestPrice":1.69,"timestamp":1749240000000,"preClose":1.74,"halted":0,"volume":165274,"hourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.69,"latestTime":"19:39 EDT","volume":4485,"amount":7574.2804,"timestamp":1749253194968},"delay":0,"floatShares":900000,"shares":71860505,"eps":-0.799245,"marketStatus":"Market Closed","change":-0.05,"latestTime":"06-06 16:00:00 EDT","open":1.78,"high":1.9,"low":1.42,"amount":280089.2197588,"amplitude":0.275862,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.799245,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1740114000000,"exchange":"NASDAQ","adjPreClose":1.74,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.74,"latestTime":"09:28 EDT","volume":628,"amount":1185.6899992,"timestamp":1749216490202},"postHourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.69,"latestTime":"19:39 EDT","volume":4485,"amount":7574.2804,"timestamp":1749253194968},"volumeRatio":1.4922961374165429},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WGRX\",,,,,undefined,":{"symbol":"WGRX","floatShares":900000,"roa":"-77.95%","roe":"-2124.65%","lyrEps":-0.145098,"volumeRatio":1.4922961374165429,"shares":71860505,"dividePrice":0,"high":1.9,"amplitude":0.275862,"preClose":1.74,"low":1.42,"week52Low":1.41,"pbRate":"27.12","psRate":"4.19","week52High":7.04,"institutionHeld":0,"latestPrice":1.69,"eps":-0.799245,"divideRate":0,"volume":165274,"delay":0,"ttmEps":-0.799245,"open":1.78,"prevYearClose":4.5,"prevWeekClose":2.01,"prevMonthClose":2.01,"prevQuarterClose":4.32,"fiveDayClose":2.01,"twentyDayClose":3,"sixtyDayClose":2.89},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WGRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521012252","title":"Wellgistics Health Achieves SOC 2 Type 1 Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2521012252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521012252?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:52","pubTimestamp":1742590371,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc ( ($WGRX) ) has shared an update. On March 17, 2025, Wellgistics Health, Inc. entered into a consulting agreement with Drape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-achieves-soc-2-type-1-compliance-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-achieves-soc-2-type-1-compliance-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ199S13.USD","LU1720051017.SGD","LU1854104046.USD","LU1548497426.USD","LU1861219969.SGD","BK4588","BK4175","LU1978683503.SGD","LU2360107325.USD","LU2298322129.HKD","LU0124384867.USD","WGRX","BK4605","BK4585","LU1861214812.USD","LU1861215975.USD","SOC","IE00BD6J9T35.USD","LU2357305700.SGD","LU0724618433.USD","BK4213","LU1861220033.SGD","BK4512","LU1720051108.HKD","ON","LU0348723411.USD","LU1854103824.USD","BK4141"],"gpt_icon":0},{"id":"2520241586","title":"Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2520241586","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520241586?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:40","pubTimestamp":1742298000,"startTime":"0","endTime":"0","summary":"TAMPA, FL, March  18, 2025  (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), a provider of pharmacy solutions and healthcare technology, has successfully completed a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/18/3044388/0/en/Wellgistics-Health-Achieves-SOC-2-Type-1-Compliance-Strengthening-Security-for-AI-Driven-Pharmacy-Solutions-and-Employer-Based-Healthcare-Models.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","HCSG","BK4137","WGRX","SOC","BK4175","ON"],"gpt_icon":0},{"id":"2517099993","title":"Wellgistics Health Appoints Brian Norton to Succeed Tim Canning as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2517099993","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517099993?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:36","pubTimestamp":1741167402,"startTime":"0","endTime":"0","summary":"Wellgistics Health (WGRX) said late Tuesday that Tim Canning will be departing as chief executive officer.The company has appointed Brian Norton as Canning's successor. Norton has experience in healthcare, technology and pharmaceutical supply chain operations, Wellgistics said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TIMB","WGRX","BK4132","BK4175"],"gpt_icon":0},{"id":"2517898778","title":"Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=2517898778","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517898778?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:35","pubTimestamp":1741127700,"startTime":"0","endTime":"0","summary":"Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4132","WGRX","TIMB"],"gpt_icon":0},{"id":"2517982661","title":"Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2517982661","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517982661?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:18","pubTimestamp":1741126680,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA97XBM8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2517936982","title":"Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936982","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517936982?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:18","pubTimestamp":1741126680,"startTime":"0","endTime":"0","summary":"TAMPA, FL, March  04, 2025  (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (the “Company”), a holding company for various existing and planned strategic businesses centered around healthc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3037022/0/en/Wellgistics-Health-Inc-Announces-Leadership-Transition-Brian-Norton-Appointed-as-CEO-Following-Tim-Canning-s-Departure.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4132","WGRX","TIMB"],"gpt_icon":0},{"id":"2517600360","title":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600360","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600360?lang=en_us&edition=fundamental","pubTime":"2025-03-05 02:46","pubTimestamp":1741114004,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN1GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAL","CAPR","NVIW.SI","WGRX","WBA","YMAB","FITB","NVDS","HUT","DSP","WVE","UAL","SLRN","3NVD.UK","ENPH","PEP","UNH","STIM","ULCC","NEXT","MDLZ","NVDD","AMLX","JBLU","EVGO","NVDY","EQT","2NVD.UK","SNVD.UK","TNYA","ILMN","PEPG","OKTA","CNX","ATEC","NVDU","AGH"],"gpt_icon":1},{"id":"2516767469","title":"BUZZ-U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516767469","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516767469?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:10","pubTimestamp":1741097444,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life SciencesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call news","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL6N3PN0J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WBA","KKR","NEM","CAPR","WVE","NVDU","NVD2.UK","DSP","EU","NVDS","NVDY","2NVD.UK","TNYA","UUUU","SLB","EBS","TGT","NVDS.UK","SNVD.UK","XOM","NVDD","NVD3.UK","LU0106261372.USD","ILMN","LU1582986433.USD","CVX","NVIW.SI","BK4135","BK4182","HUT","3NVD.UK","TSYW.SI","WGRX","LU0203201768.USD","UEC","BAC","LU0496367417.USD","BBY"],"gpt_icon":1},{"id":"2516794586","title":"BUZZ-Wellgistics rises on collaboration with Protega Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2516794586","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516794586?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:40","pubTimestamp":1741095628,"startTime":"0","endTime":"0","summary":"BUZZ-Wellgistics rises on collaboration with Protega Pharmaceuticals** Shares of New Jersey-based drug distributor Wellgistics Health WGRX.O rise 9.3% to $2.95 premarket** Company announces it is collaborating with Protega Pharmaceuticals to increase patient access to Protega's opioid, Roxybond** Roxybond is indicated for managing severe pain when other treatments are insufficient** WGRX has fallen 29% since its debut on February 21  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN17X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2516679980","title":"BRIEF-Protega Pharmaceuticals Collaborates With Wellgistics To Support Pharmacist Education","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679980","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679980?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:35","pubTimestamp":1741095312,"startTime":"0","endTime":"0","summary":"BRIEF-Protega Pharmaceuticals Collaborates With Wellgistics To Support Pharmacist Education March 4 (Reuters) - Wellgistics Health Inc WGRX.O:PROTEGA PHARMACEUTICALS COLLABORATES WITH WELLGISTICS TO S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA9523NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2516673196","title":"Protega Pharmaceuticals Collaborates With Wellgistics to Support Pharmacist Education and Increase Patient Access to the First and Only FDA-Approved Abuse-Deterrent Immediate-Release Opioid, Roxybond™","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673196","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673196?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:40","pubTimestamp":1741092000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA9523NH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2516737686","title":"Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™","url":"https://stock-news.laohu8.com/highlight/detail?id=2516737686","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516737686?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:40","pubTimestamp":1741092000,"startTime":"0","endTime":"0","summary":"ROXYBOND, formulated with patented, first-of-its-kind abuse-deterrent technology SentryBond, is designed to provide multiple levels of protection. Wellgistics LLC is a pharmaceutical wholesaler and National Association of Boards of Pharmacy  authorized distributor that serves over 5,400 independent pharmacies across all 50 states. The relationship will support education to these pharmacies and help provide distribution of ROXYBOND to appropriately prescribed patients, particularly in underserved and rural areas where Wellgistics LLC’s independent pharmacy clients play a critical role in patient care.\"Regulatory integrity and patient safety are the foundation of everything we do at Wellgistics Health . As an NABP-authorized distributor, and utilizing a fully serialized ERP for supply chain traceability —we ensure independent pharmacies have the tools, education, and access they need to dispense medications like ROXYBOND responsibly,” said Brian Norton, Chief Executive officer of the Com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protega-pharmaceuticals-collaborates-wellgistics-support-124000296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IR","LU0417517546.SGD","IE00BHPRN162.USD","BK4007","LU1978683503.SGD","BK4588","BK4109","CSA","LU2346227817.USD","OIH","LU0124384867.USD","BK4175","LU0256863902.USD","BK4547","IE00BD4GTT62.SGD","LU0256863811.USD","BK4161","CE","CNS","LU0149725797.USD","SAVA","BK4135","IE00BD4GTW91.USD","WGRX","SG9999001440.SGD","BK4585","LU2449327464.USD","IE00BD4GTV84.USD","BK4081","PCG"],"gpt_icon":0},{"id":"2516530076","title":"Wellgistics Health Expands with Tollo Health Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2516530076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516530076?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:29","pubTimestamp":1740781779,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc ( ($WGRX) ) just unveiled an update. On February 25, 2025, Wellgistics Health, Inc. entered into a consulting agreement with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-expands-with-tollo-health-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-expands-with-tollo-health-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGRX"],"gpt_icon":0},{"id":"2514205834","title":"Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2514205834","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514205834?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:40","pubTimestamp":1740573600,"startTime":"0","endTime":"0","summary":"“We are excited to partner with the team at Tollo, who bring in-depth scientific and medical knowledge in both the areas of muscle loss and chronic viral infections”, said Jason Lang, Vice President of Business Development of Wellgistics LLC. “We believe that our expansion into medical foods will directly impact our pharmacy clients and support physicians and the patients they serve. Managing the side effects of GLP-1 drugs and the devastating impacts of Long COVID remains a challenge because there are no approved prescription treatment options currently available. It only makes sense to look at natural products, backed by cutting edge scientific research, with no known side effects, to help manage these conditions. We recognize that sometimes medical foods are the only viable solutions to help our clients improve patient outcomes. We plan to work with Tollo and our clients to generate industry leading data on Tollo’s suite of products and make them broadly available to the pharmacies ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wellgistics-expands-healthcare-ecosystem-tollo-124000891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HCSG","BK4137","BK4590","BK4144","GLP","WGRX"],"gpt_icon":0},{"id":"2514705410","title":"Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514705410?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:05","pubTimestamp":1740431102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA7SFN37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX"],"gpt_icon":0},{"id":"2514706609","title":"Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2514706609","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514706609?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:05","pubTimestamp":1740431100,"startTime":"0","endTime":"0","summary":"Tampa, Florida, Feb.  24, 2025  (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (the \"Company\"), a holding company for various existing and planned strategic businesses centered around healthcare technol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031521/0/en/Wellgistics-Health-Inc-Announces-Closing-of-4-0-Million-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX"],"gpt_icon":0},{"id":"2513689293","title":"BRIEF-Wellgistics Health Announces Pricing Of $4.0 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2513689293","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513689293?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:07","pubTimestamp":1740146875,"startTime":"0","endTime":"0","summary":"BRIEF-Wellgistics Health Announces Pricing Of $4.0 Million Initial Public OfferingFeb 21 (Reuters) - Wellgistics Health Inc WGRX.O:WELLGISTICS HEALTH, INC. ANNOUNCES PRICING OF $4.0 MILLION INITIAL PU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nTUA9XCVLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX"],"gpt_icon":0},{"id":"2513619260","title":"Wellgistics Health Prices $4 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2513619260","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513619260?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:25","pubTimestamp":1740144318,"startTime":"0","endTime":"0","summary":"Wellgistics Health said Friday it has priced its initial public offering of 888,889 ordinary shares at $4.50 per share for gross proceeds of $4 million.The shares are expected to start trading on the Nasdaq under the ticker symbol \"WGRX\" on Feb. 21, the company said.The company said the net proceeds from the offering, which is expected to close on or about Feb. 24, will be used mainly for general corporate purposes, including working capital, marketing initiatives and capital expenditures.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WGRX"],"gpt_icon":0},{"id":"2513826761","title":"Wellgistics Health Inc - Prices IPO of 888,889 Shares at $4.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2513826761","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513826761?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:05","pubTimestamp":1740143100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nTUA9XCVLK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX"],"gpt_icon":0},{"id":"2513636267","title":"Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2513636267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513636267?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:05","pubTimestamp":1740143100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nTUA9XCVLK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WGRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"WGRX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WGRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WGRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WGRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WGRX","date":"2025-06-06","current":-2.734539,"percent":0.986486,"low":-72.147882,"twenty":-41.721411,"median":-31.592911,"eighty":-3.859787,"high":-2.386928,"avg":-29.762639,"sd":18.778863,"marketCap":107204904},"quantilePoints":[{"date":"2025-02-21","current":-72.147882,"twenty":-72.147882,"median":-72.147882,"eighty":-72.147882,"marketCap":259777540},{"date":"2025-02-28","current":-42.846677,"twenty":-68.711291,"median":-43.712266,"eighty":-40.423027,"marketCap":154274859},{"date":"2025-03-07","current":-41.836823,"twenty":-52.714396,"median":-41.836823,"eighty":-39.470878,"marketCap":150638751},{"date":"2025-03-14","current":-38.51873,"twenty":-43.539148,"median":-41.404028,"eighty":-38.951524,"marketCap":138691539},{"date":"2025-03-21","current":-68.309433,"twenty":-56.926931,"median":-41.836823,"eighty":-39.038083,"marketCap":245956719},{"date":"2025-03-28","current":-29.320039,"twenty":-57.648256,"median":-41.836823,"eighty":-38.951524,"marketCap":201024816},{"date":"2025-04-04","current":-34.168831,"twenty":-57.330873,"median":-41.548293,"eighty":-35.027382,"marketCap":234269230},{"date":"2025-04-11","current":-29.623089,"twenty":-56.580696,"median":-39.817114,"eighty":-32.608127,"marketCap":203102592},{"date":"2025-04-17","current":-27.804792,"twenty":-54.964929,"median":-38.951524,"eighty":-29.850376,"marketCap":190635936},{"date":"2025-04-25","current":-32.350534,"twenty":-50.348452,"median":-38.446597,"eighty":-29.623089,"marketCap":221802575},{"date":"2025-05-02","current":-32.786877,"twenty":-43.712266,"median":-34.623406,"eighty":-29.850376,"marketCap":224794239},{"date":"2025-05-09","current":-22.874565,"twenty":-42.846677,"median":-34.582242,"eighty":-29.850376,"marketCap":156833190},{"date":"2025-05-16","current":-3.107007,"twenty":-41.836823,"median":-34.006854,"eighty":-28.941227,"marketCap":121807110},{"date":"2025-05-23","current":-3.897505,"twenty":-41.836823,"median":-32.863125,"eighty":-24.925822,"marketCap":152797794},{"date":"2025-05-30","current":-3.661768,"twenty":-41.836823,"median":-32.653584,"eighty":-18.358625,"marketCap":143555992},{"date":"2025-06-06","current":-2.734539,"twenty":-41.721411,"median":-31.592911,"eighty":-3.859787,"marketCap":107204904}],"updateTime":1749346616160}}}